JPRN-UMIN000002264已完成未知
Effects of Miglitol on Endothelial Vascular Reactivity in Type 2 Diabetic Patients with Coronary Heart Disease - J-MACH
Department of Cardiovascular Medicine, Juntendo University School of Medicine0 个研究点目标入组 12 人开始时间: 2009年7月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Type 1 diabetes. Patients receiving insulin therapy. Patients with one of the following clinical conditions: severe liver dysfunction, severe renal dysfunction, congestive heart failure, acute coronary syndrome within 3 months, and other severe concomitant diseases. Patients who are judged inappropriate for entry into this study by the investigator.
研究者
相似试验
已完成
不适用
Effect of sitagliptin on vascular endothelial function in Type 2 diabetesType 2 diabetesJPRN-UMIN000009948Tokyo Women's Medical University50
已完成
3 期
The effect of vildagliptin on endothelium-dependent vasodilatation. A double blind, cross-over study in type 2 diabetes mellitus.endothelial functionEndothelium-dependent vasodilatation1001265310003216NL-OMON32871niversitair Medisch Centrum Sint Radboud16
进行中（未招募）
1 期
The effect of vildagliptin on endothelium-dependent vasodilatation. A double blind, cross-over study in type 2 diabetes. - Vildagliptin and vasodilatatioThe effect of vildagliptin on endothelial dysfunction in type 2 diabetes, assessed by measuring endothelium-dependent vasodilatationMedDRA version: 12.0Level: LLTClassification code 10048554Term: Endothelial dysfunctionEUCTR2009-016053-18-NLMC St Radboud16
已完成
不适用
Effect of alogliptin on endothelial dysfunction induced by postprandial hypelipidemiaJPRN-UMIN000008296Department of Cardiovascular Medicin,Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama30
已完成
不适用
Effect of alogliptin on endothelial dysfunction induced by hyperlipidemiahaelthy subjects patients wiht coronary artery disease subjects wiht metabolic symdromeJPRN-UMIN000008297Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences60